Tag: NASDAQ:SPEX

  • Top Losers – Spherix Inc (NASDAQ:SPEX), Infinity Energy Resources Inc. (OTCMKTS:IFNY), Actions Semiconductor Co (NASDAQ:ACTS), Cell Therapeutics (NASDAQ:CTIC)

    Spherix Inc (NASDAQ:SPEX) — an intellectual property development company committed to the fostering and monetization of intellectual property, is very proud to announce that its CEO, Anthony Hayes has been named one of the top 10 personalities of the year of 2013 by IAM. Spherix Inc (NASDAQ:SPEX) stock opened at $7.45 in last session, and closed at $5.83, while the day range of stock is $5.35 – $7.45. The stock showed a positive/negative weekly performance of -29.16%.

    Infinity Energy Resources, Inc. (OTCQB:IFNY), an independent oil and gas exploration and development company, announced that it will be presenting at “TEN”, Noble Financial Capital Markets’ Tenth Annual Equity Conference on Monday, January 20, 2014. The conference will be held at the Club Med in Sandpiper Bay, Florida (West Palm Beach area). Infinity Energy Resources Inc. (OTCMKTS:IFNY) stock opened at $1.38, in last session and closed at $1.07, by losing -23.02%. The 52 week range of the stock is $0.95 – $3.75. Company’s market capitalization is $22.95 million.

    Actions Semiconductor Co., Ltd. (ADR) (NASDAQ:ACTS), one of China’s leading fabless semiconductor companies that provides comprehensive portable multimedia and mobile internet system-on-a-chip (SoC) solutions for portable consumer electronics, announced it will release financial results for the fourth quarter and year ended December 31, 2013, before the market opens on Monday, January 27, 2014. The company will host a corresponding conference call and live webcast at 8:00 a.m. Eastern Time on that day. Actions Semiconductor Co., Ltd. (ADR) (NASDAQ:ACTS) stock decreased -16.61% and finished the last session at $2.31. The EPS of the stock remained -0.01. Company’s market capitalization is $157.46 million.

    Cell Therapeutics Inc (NASDAQ:CTIC) announced Tuesday an overview of recent progress for its drug portfolio, noting that it has entered 2014 with a series of successes. Cell Therapeutics Inc (NASDAQ:CTIC) stock opened the session at $3.79, and closed the session at $3.34. The 52 week range of the stock remained $0.97 – $4.25 and the day range was $3.03 – $3.81.